Richard A. Heyman is of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 45,300 shares of ORIC, which is worth approximately $563,985. The most recent transaction as insider was on Oct 03, 2025, when has been sold 32,800 shares (Common Stock) at a price of $2.68 per share, resulting in proceeds of $87,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.3K
n/a 3M change
n/a 12M change
Total Value Held $563,985

Richard A. Heyman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2025
BUY
Exercise of conversion of derivative security
$87,904 $2.68 p/Share
32,800 Added 42.0%
45,300 Common Stock

Also insider at

PMVP
PMV Pharmaceuticals, Inc. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
MTCR
Metacrine, Inc. Healthcare
GRTS
Gritstone bio, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
RYZB
RayzeBio, Inc.
RAH

Richard A. Heyman

San Diego, CA

Track Institutional and Insider Activities on ORIC

Follow Oric Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC